Lipoma is a benign mesenchymal tumor composed of mature adipocytes and represents the most common soft tissue tumor encountered in clinical practice. Although frequently asymptomatic and slow growing, lipomas may occasionally present diagnostic challenges when they occur in atypical locations, exhibit rapid growth, or cause compressive symptoms. Pediatric lipomas are relatively uncommon compared to adult cases and require careful evaluation to differentiate them from other benign and malignant soft tissue tumors.
We report a case of a subcutaneous lipoma in a pediatric patient presenting with a progressively enlarging, painless limb swelling. This case underscores the importance of thorough clinical examination, appropriate imaging for lesion characterization, histopathological confirmation, and a multidisciplinary approach to management to ensure optimal outcomes and avoid unnecessary interventions.
Lipomas are benign tumors originating from adipose tissue and account for nearly half of all soft tissue tumors [1]. They are typically encapsulated, well circumscribed, and composed of mature fat cells without cellular atypia. Lipomas can occur anywhere in the body but are most commonly found in the subcutaneous tissues of the trunk, neck, shoulders, and proximal extremities.
While lipomas predominantly affect adults between the fourth and sixth decades of life, they may occasionally present in children and adolescents. Pediatric lipomas constitute a small proportion of soft tissue tumors and pose unique diagnostic considerations due to the broader differential diagnosis in this age group, including lipoblastoma, fibromatosis, vascular malformations, and soft tissue sarcomas [2].
Most lipomas are clinically benign and require no intervention unless symptomatic. However, lesions that increase in size, cause discomfort, restrict movement, or raise cosmetic or diagnostic concerns warrant further evaluation. Imaging modalities such as ultrasonography and magnetic resonance imaging (MRI) play a pivotal role in lesion characterization and surgical planning.
A 9-year-old female child was brought to the pediatric outpatient department with a complaint of a painless swelling over the posterior aspect of the left upper arm. The swelling was first noticed approximately six months prior and had gradually increased in size over time. There was no associated pain, redness, warmth, or history of trauma.

The caregivers denied any history of fever, weight loss, night sweats, or reduced appetite. There was no limitation of limb movement or interference with daily activities. The child had no significant past medical history and was not on long-term medication. Family history was unremarkable, with no known hereditary or connective tissue disorders.
On physical examination, the child was afebrile and hemodynamically stable. General examination revealed no pallor, lymphadenopathy, or signs of systemic illness.
Local examination of the left upper arm revealed a well-defined, soft, non-tender, and mobile mass measuring approximately 4 × 3 cm in the subcutaneous plane. The swelling had a smooth surface, was not adherent to the overlying skin or underlying muscle, and showed no signs of inflammation. The overlying skin appeared normal, with no discoloration or ulceration.

Neurovascular examination of the affected limb was normal, and there was full range of motion at the shoulder and elbow joints. Examination of other systems did not reveal any abnormalities.
Based on the clinical presentation, the following differential diagnoses were considered:
Given the slow growth, soft consistency, mobility, and absence of systemic symptoms, a benign soft tissue lesion was suspected. However, imaging was planned to further characterize the lesion and exclude malignancy.
Ultrasound examination of the swelling revealed a well-circumscribed, homogenous, hyperechoic lesion located in the subcutaneous tissue. The lesion showed no internal calcification or cystic components and minimal internal vascularity on Doppler evaluation, favoring a benign fatty lesion.

Magnetic resonance imaging (MRI) of the left upper arm was performed for further evaluation. MRI demonstrated a well-encapsulated lesion that was hyperintense on T1-weighted and T2-weighted images, with complete signal suppression on fat-suppressed sequences. There was no evidence of internal septal thickening, nodularity, hemorrhage, or invasion into adjacent muscular structures. These findings were highly suggestive of a benign lipomatous tumor.

Based on the clinical features and imaging characteristics, a provisional diagnosis of subcutaneous lipoma was made. Surgical excision was planned both for definitive diagnosis and to alleviate parental concern.
The case was managed through a multidisciplinary team involving pediatric surgery, radiology, anesthesia, and pathology. Detailed counseling was provided to the caregivers regarding the benign nature of the lesion, the need for surgical excision, and the low risk of recurrence.
The child underwent complete surgical excision of the mass under general anesthesia. Intraoperatively, a well-encapsulated, yellowish, lobulated fatty mass was identified in the subcutaneous plane and excised in toto without complications. There was no involvement of underlying muscle or neurovascular structures.
The excised specimen was sent for histopathological examination.

Microscopic examination revealed mature adipocytes arranged in lobules separated by thin fibrous septae. There was no evidence of cellular atypia, lipoblasts, necrosis, or mitotic activity. These findings confirmed the diagnosis of a benign lipoma.
The postoperative period was uneventful, and the child was discharged on the second postoperative day. At follow-up visits conducted at one month, three months, and six months, the patient remained asymptomatic with no evidence of recurrence. The surgical scar healed well, and the cosmetic outcome was satisfactory.

Lipomas are benign adipocytic tumors with an excellent prognosis following complete excision. In pediatric patients, differentiation from lipoblastoma is particularly important, as lipoblastomas are more common in younger children and may show infiltrative growth patterns [3].
MRI is the imaging modality of choice for evaluating soft tissue tumors due to its superior soft tissue contrast and ability to delineate lesion extent. Typical lipomas demonstrate uniform fat signal intensity without suspicious features such as thick septae, nodularity, or enhancement, which may raise concern for liposarcoma [4].
Surgical excision is curative in the majority of cases and is indicated for symptomatic lesions, diagnostic uncertainty, or cosmetic reasons. Recurrence is rare and usually related to incomplete excision.
Lipoma should be considered in the differential diagnosis of painless, slowly enlarging soft tissue masses in pediatric patients. A structured diagnostic approach incorporating careful clinical evaluation, appropriate imaging, and histopathological confirmation is essential for accurate diagnosis and management. Multidisciplinary coordination and caregiver counseling play a key role in ensuring favorable outcomes and preventing unnecessary anxiety or interventions.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation